Replies to post #256146 on Biotech Values

[WorstLuck]

MTSR
From the 14A

(i) the risk-adjusted net present value of the September 14 Pfizer Proposal per share of Metsera common stock was $51.64 as calculated by Goldman Sachs and $51.73 as calculated by Guggenheim Securities, (ii) the risk-adjusted net present value of the September 20 Party 1 Proposal per share of Metsera common stock was $59.46 as calculated by Goldman Sachs and $59.62 as calculated by Guggenheim Securities,

MTSR trading consistently above the rNPV as calculated by Guggenheim and GS is interesting, is there a higher bid coming?

[alertmeipp]

Interesting, I would think some of those bidders would be interested in $VKTX as well. I thought it is the front runner.. but everyone else seems to have gotten a deal but it... how puzzling.


>> Had 6 other bidders in including one higher offer which was on a timeline